P1.01-28 Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients with EGFR Mutation-Positive Advanced NSCLC
Year: 2018
Type: article
Study design: Observational Study
Source: Journal of Thoracic Oncology
Authors: B. Halmos, E. Tan, R. Soo, J. Cadranel, M.K. Lee, P. Foucher, T. Hsia, M. Hochmair, F. Griesinger, T. Hida, E. Kim, B. Melosky, A. Märten, E. Carcereny
Institutions: Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, National Cancer Centre Singapore, National University Hospital, Sorbonne Université, Hôpital Tenon, Pusan National University Hospital, CHU Dijon Bourgogne, China Medical University, China Medical University Hospital, China Medical University, Otto Wagner Hospital, Carl von Ossietzky Universität Oldenburg, Pius Hospital Oldenburg, Aichi Cancer Center, Levine Cancer Institute, University of British Columbia, Boehringer Ingelheim (Germany), Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2898356642